Works matching IS 14752840 AND DT 2025 AND VI 24 AND IP 1

Results: 232
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02778-6
    By:
    • Pugliese, Nicola Riccardo;
    • Paneni, Francesco;
    • Tricò, Domenico;
    • Bacca, Alessandra Violet;
    • De Biase, Nicolò;
    • Dalpiaz, Hermann;
    • Mengozzi, Alessandro;
    • Virdis, Agostino;
    • Ghiadoni, Lorenzo;
    • Taddei, Stefano;
    • Kreutz, Reinhold;
    • Tsioufis, Konstantinos;
    • Masi, Stefano
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    The effects of SGLT2i on cardiac metabolism in patients with HFpEF: Fact or fiction?

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02767-9
    By:
    • Cinti, Francesca;
    • Laborante, Renzo;
    • Cappannoli, Luigi;
    • Morciano, Cassandra;
    • Gugliandolo, Shawn;
    • Pontecorvi, Alfredo;
    • Burzotta, Francesco;
    • Donniacuo, Maria;
    • Cappetta, Donato;
    • Patti, Giuseppe;
    • Giaccari, Andrea;
    • D'Amario, Domenico
    Publication type:
    Article
    22
    23
    24
    25

    Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02734-4
    By:
    • Delalat, Simin;
    • Sultana, Innas;
    • Osman, Hersh;
    • Sieme, Marcel;
    • Zhazykbayeva, Saltanat;
    • Herwig, Melissa;
    • Budde, Heidi;
    • Kovács, Árpád;
    • Kaçmaz, Mustafa;
    • Göztepe, Eda;
    • Borgmann, Natalie;
    • Shahriari, Gelareh;
    • Sasko, Benjamin;
    • Wintrich, Jan;
    • Haldenwang, Peter;
    • Schmidt, Wolfgang E.;
    • Fenske, Wiebke;
    • Khan, Muchtiar;
    • Jaquet, Kornelia;
    • Mügge, Andreas
    Publication type:
    Article
    26
    27
    28

    Diabetes mellitus aggravates myocardial inflammation and oxidative stress in aortic stenosis: a mechanistic link to HFpEF features.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02748-y
    By:
    • Herwig, Melissa;
    • Sieme, Marcel;
    • Kovács, Andrea;
    • Khan, Muchtiar;
    • Mügge, Andreas;
    • Schmidt, Wolfgang E.;
    • Elci, Ferhat;
    • Sasidharan, Shan;
    • Haldenwang, Peter;
    • Wintrich, Jan;
    • Sasko, Benjamin;
    • Akin, Ibrahim;
    • Domokos, Máthé;
    • Paneni, Francesco;
    • El-Battrawy, Ibrahim;
    • Varga, Zoltán V.;
    • Saraiva, Francisca;
    • Leite-Moreira, Adelino F.;
    • Ferdinandy, Péter;
    • van Heerebeek, Loek
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36

    Life's Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02735-3
    By:
    • Li, Mian;
    • Xu, Min;
    • Ding, Yi;
    • Lin, Hong;
    • Qin, Guijun;
    • Wang, Tiange;
    • Xu, Yu;
    • Chen, Yuhong;
    • Wang, Shuangyuan;
    • Zhao, Zhiyun;
    • Zheng, Jie;
    • Yan, Li;
    • Shi, Lixin;
    • Gao, Zhengnan;
    • Chen, Lulu;
    • Zeng, Tianshu;
    • Hu, Ruying;
    • Ye, Zhen;
    • Yu, Xuefeng;
    • Chen, Gang
    Publication type:
    Article
    37
    38
    39

    Correction: Visceral adipose tissue mediates the relationship between left ventricular global longitudinal strain and insulin resistance among adults living with type 2 diabetes.

    Published in:
    2025
    By:
    • Martinez-Dominguez, Pavel;
    • Gomez-Aviles, Paola;
    • Bautista-García, Kenya;
    • Antonio-Villa, Neftali Eduardo;
    • Guerra, Enrique C.;
    • Almeda-Valdes, Paloma;
    • Martagón, Alexandro J.;
    • Munoz, Alejandro Campos;
    • Santa-Ana-Bayona, Maria Jose;
    • Alexanderson, Erick;
    • Salinas, Carlos A. Aguilar;
    • Espinola-Zavaleta, Nilda
    Publication type:
    Correction Notice
    40
    41
    42
    43

    Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02745-1
    By:
    • Teragawa, Hiroki;
    • Tanaka, Atsushi;
    • Takahashi, Kanae;
    • Oshita, Chikage;
    • Uchimura, Yuko;
    • Kamei, Nozomu;
    • Hirai, Hiroyuki;
    • Shimabukuro, Michio;
    • Taguchi, Isao;
    • Okada, Yosuke;
    • Node, Koichi
    Publication type:
    Article
    44
    45

    CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02700-0
    By:
    • Schnell, Oliver;
    • Almandoz, Jaime;
    • Anderson, Lisa;
    • Barnard-Kelly, Katharine;
    • Battelino, Tadej;
    • Blüher, Matthias;
    • Busetto, Luca;
    • Catrinou, Doina;
    • Ceriello, Antonio;
    • Cos, Xavier;
    • Danne, Thomas;
    • Dayan, Colin M.;
    • Del Prato, Stefano;
    • Fernández-Fernández, Beatriz;
    • Fioretto, Paola;
    • Forst, Thomas;
    • Gavin, James R.;
    • Giorgino, Francesco;
    • Groop, Per-Henrik;
    • Harsch, Igor A.
    Publication type:
    Article
    46
    47
    48
    49
    50